Case ReportRecall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation
References (10)
- et al.
Rate of biodistribution of STEALTH liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity
Biochim Biophys Acta
(2003) - et al.
Skin toxicity associated with pegylated liposomal doxorubicin (40 mg/m2) in the treatment of gynaecologic cancers
Gynecol Oncol
(2005) - et al.
Grade 3 liposomal-doxorubicin-induced skin toxicity in a patient following complete resolution of moderately severe sunburn
Gynecol Oncol
(2004) - et al.
Treatment of anthracycline extravasation with dexrazoxane
Clin Cancer Res
(2000) - et al.
Lack of vescicant injury following extravasation of liposomal doxorubicin
J Natl Cancer Inst
(1995)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2006 Elsevier Ltd. All rights reserved.